Workflow
浙江华康药业股份有限公司关于因实施权益分派调整“华康转债”转股价格的公告

Core Viewpoint - The announcement details the adjustment of the conversion price for the company's convertible bonds due to the implementation of a profit distribution plan for the first half of 2025, resulting in a decrease in the conversion price from 16.46 CNY to 16.26 CNY per share [2][3][6]. Group 1: Conversion Price Adjustment - The initial conversion price of the "Huakang Convertible Bonds" was set at 22.66 CNY per share, which has undergone several adjustments due to various corporate actions [5]. - The conversion price was adjusted to 16.89 CNY per share on May 28, 2024, and further adjusted to 16.39 CNY on April 24, 2025, before the latest adjustment [5]. - The new conversion price of 16.26 CNY per share will take effect on September 29, 2025, following the distribution of a cash dividend of 0.2 CNY per share [3][6]. Group 2: Profit Distribution Plan - The company plans to distribute a cash dividend of 0.2 CNY per share, amounting to a total of approximately 6,060.99622 million CNY based on the total share capital of 30,304.9811 million shares [11][13]. - The profit distribution plan was approved during the second extraordinary general meeting of shareholders held on September 8, 2025 [11]. - The distribution will be executed through the Shanghai Clearing House, with specific procedures outlined for both unrestricted and restricted shareholders [14][16].